Type 1 and Type 2 diabetes are major causes of morbidity and premature death globally. The Diabetes group takes a multi-faceted approach, studying both common types of diabetes in cell and animal models and in human observational studies and clinical trials.
CTC’s Diabetes team aims to improve the prediction of diabetes onset and its complications, to explore underlying mechanisms of disease and treatment benefit, and to test drugs, devices and models of care, including telehealth, that can improve outcomes for people with diabetes.
For more information, contact Alicia Jenkins, Professor, Diabetes and Vascular Medicine.
